Search Within

Howard Scher

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (127)
  2. Meeting Abstract (71)
  3. Research Letter (2)
Groups
  1. Department of Medicine (200)
  2. Epidemiology and Biostatistics (200)
  3. Genitourinary Oncology Service (200)
  4. Solid Tumor Oncology Division (200)
  5. Biostatistics Service (159)
  6. GSK Faculty (108)

More Groups

People
  1. Glenn Heller (89)
  2. Michael Morris (66)
  3. Nikolaus Schultz (42)
  4. Daniel Danila (39)
  5. Steven Larson (38)
  6. David Solit (37)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (3)
  4. 2022 (8)
  5. 2021 (7)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (63)
  2. Clinical Cancer Research (23)
  3. Cancer Research (13)
  4. Urology (7)
  5. European Urology (6)
  6. Journal of Nuclear Medicine (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (66)
  2. American Association for Cancer Research (43)
  3. Elsevier Science, Inc. (19)
  4. Nature Publishing Group (14)
  5. Elsevier Inc. (7)
  6. Society of Nuclear Medicine (6)

More Publishers

Results (200)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Validation and clinical utility of prostate cancer biomarkers
    Journal Article

    Scher, H. I.; Morris, M. J.; Larson, S.; Heller, G.
    Nature Reviews Clinical Oncology (2013)

    Fulltext@MSK | Save
  • β4 Integrin signaling induces expansion of prostate tumor progenitors
    Journal Article

    Yoshioka, T.; Otero, J.; Chen, Y.; Kim, Y. M.; Koutcher, J. A.; Satagopan, J.; Reuter, V.; Carver, B.; de Stanchina, E.; Enomoto, K.; more...
    Journal of Clinical Investigation (2013)

    Fulltext@MSK | Save
  • The analytic validation of prostate-specific mRNA detection in whole blood by RT-PCR as a prognostic biomarker for patients with castration- resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D. C.; Anand, A.; Heller, G.; Wan, M.; Zehnder, M.; Khanin, R.; Schultz, N.; Fleisher, M.; Lilja, H.; Scher, H. I.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) PET as a prognostic biomarker for survival in patients with metastatic castrate-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Jia, X.; Heller, G.; Schoder, H.; Humm, J.; Haupt, E. C.; Schneider, C.; Scher, H. I.; Larson, S. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Does the catalytic activity of prostate-specific antigen (PSA) or kallikrein-related peptidase 2 (hK2) secreted by novel transgenic mice models critically influence development of prostate cancer or release of PSA or hK2 in blood
    Meeting Abstract

    Braun, K.; Ulmert, D.; von Bodman, C.; Byers, A.; Mehta, D.; Johnson, L.; Wenske, S.; Hricik, T.; Heller, G.; Scher, H.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: Potential for rapid monitoring of treatment responses
    Journal Article

    Ulmert, D.; Vickers, A. J.; Scher, H. I.; Becker, C.; Iversen, P.; Frankel, D.; Jensen, J. K.; Olesen, T. K.; Lilja, H.
    Clinical Chemistry and Laboratory Medicine (2012)

    Fulltext@MSK | Save
  • Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors
    Journal Article

    Mitsiades, N.; Sung, C. C.; Schultz, N.; Danila, D. C.; He, B.; Eedunuri, V. K.; Fleisher, M.; Sander, C.; Sawyers, C. L.; Scher, H. I.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • The analytical validation of prostate specific mRNA detection in whole blood by reverse transcription-polymerase chain reaction (RT-PCR) as a prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D.; Anand, A.; Heller, G.; Wan, M.; Zehnder, M.; Khanin, R.; Schultz, N.; Fleisher, M.; Lilja, H.; Scher, H. I.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Reproducibility and clinical correlations of post-treatment changes on CT of prostate cancer bone metastases treated with chemotherapy
    Journal Article

    Gourtsoyianni, S.; Hwang, S.; Panicek, D. M.; Zheng, J.; Moskowitz, C.; Scher, H.; Morris, M.; Hricak, H.
    British Journal of Radiology (2012)

    Fulltext@MSK | Save
  • Locally advanced prostate cancer: A population-based study of treatment patterns
    Journal Article

    Lowrance, W. T.; Elkin, E. B.; Yee, D. S.; Feifer, A.; Ehdaie, B.; Jacks, L. M.; Atoria, C. L.; Zelefsky, M. J.; Scher, H. I.; Scardino, P. T.; more...
    BJU International (2012)

    Fulltext@MSK | Save